'Double whammy' for Roche as manufacturing patent losses loom

'Double whammy' for Roche as manufacturing patent losses loom


Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed. Roche's so-called "Cabilly patents" protect a pivotal step in manufacturing therapeutic antibodies, but end on Dec. 18, 2018.



from Biotech News